• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.03% Nasdaq Up 0.33%

    Navidea Biopharmaceuticals, Inc (NAVB)

    -NYSE MKT
    1.70 Down 0.02(1.16%) 4:00PM EDT
    |After Hours : 1.70 0.00 (0.00%) 4:36PM EDT
    Add to Portfolio
    Prev Close:1.72
    Open:1.72
    Bid:1.10 x 1000
    Ask:1.71 x 500
    1y Target Est:4.80
    Beta:-0.12
    Next Earnings Date:30-Jul-15NAVB Earnings announcement
    Day's Range:1.66 - 1.72
    52wk Range:0.97 - 2.02
    Volume:1,143,688
    Avg Vol (3m):529,453
    Market Cap:256.24M
    P/E (ttm):N/A
    EPS (ttm):-0.21
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NAVB

    Comparison

    Symbol% ChgMkt Cap
    NAVBDown 1.16%256.24M
    LLYDown 0.65%89.53B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):33.79
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.19
    Quarterly EPS Est (Jun-15) :-0.04
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Navidea Biopharmaceuticals, Inc., a precision medicine company, focuses on the development and commercialization of precision diagnostics, therapeutics, and radiopharmaceutical agents. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback